SIM
ADMS

Spark Investment Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Spark Investment Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-55,900
Closed -$935K – 890
2015
Q3 		$935K Sell
55,900
-3,400
-6% -$77.4K 0.12% 266
2015
Q2 		$1.55M Sell
59,300
-16,200
-21% -$315K 0.22% 153
2015
Q1 		$1.32M Buy
75,500
+10,300
+16% +$176K 0.18% 185
2014
Q4 		$1.13M Buy
65,200
+44,900
+221% +$681K 0.19% 176
2014
Q3 		$376K Buy
20,300
+6,900
+51% +$119K 0.06% 403
2014
Q2 		$244K Buy
+13,400
New +$240K 0.04% 456

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Spark Investment Management's ADMS Position: Q4 2015 in Review

Spark Investment Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2015, closing a stake of 55,900 shares — an estimated $935K sold.

Spark Investment Management first reported a position in ADMS in Q2 2014 and held it in 6 quarters. The position peaked at $1.55M in Q2 2015. 93 funds tracked by Wall St. Rank hold ADMS as of Q4 2015.

  • Spark Investment Management reported no remaining Adamas Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Spark Investment Management sold 55,900 Adamas Pharmaceuticals shares in Q4 2015, an estimated $935K.
  • Spark Investment Management first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 6 quarters.
  • Spark Investment Management's Adamas Pharmaceuticals position peaked at $1.55M in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2015.

Based on Spark Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.